Original Contributions |
From Children's Hospital Medical Center, Division of Critical Care, Cincinnati, Ohio.
Correspondence to Basilia Zingarelli, MD, PhD, Children's Hospital Medical Center, Division of Critical Care, 3333 Burnet Ave, Cincinnati, OH 45229. E-mail bzingarelli{at}chmcc.org
AbstractThe nuclear enzyme poly (ADP-ribose) synthetase (PARS) has been shown to play an important role in the pathogenesis of ischemia/reperfusion injury and circulatory shock. The aim of this study was to investigate whether PARS activity may modulate endothelial-neutrophil interaction. We present evidence that genetic disruption of PARS provides protection against myocardial ischemia and reperfusion injury by inhibiting the expression of P-selectin and intercellular adhesion molecule-1 (ICAM-1) and, consequently, by inhibiting the recruitment of neutrophils into the jeopardized tissue. Furthermore, using in vitro studies, we demonstrate that in fibroblasts lacking a functional gene for PARS, cytokine-stimulated expression of ICAM-1 is significantly reduced compared with fibroblasts from animals with a normal genotype. Similarly, in cultured human endothelial cells, oxidative- or cytokine-dependent expression of P-selectin and ICAM-1 is reduced by pharmacological inhibition of PARS by 3-aminobenzamide. These findings provide the first direct evidence that PARS activation participates in neutrophil-mediated myocardial damage by regulating the expression of P-selectin and ICAM-1 in ischemic and reperfused myocardium, and they also provide the basis for a novel therapeutic approach for the treatment of reperfusion injury.
Key Words: nitric oxide peroxynitrite cell adhesion molecule neutrophil 3-aminobenzamide
This article has been cited by other articles:
![]() |
A. Tasatargil, M. Tekcan, C. Celik-Ozenci, N. Ece Gungor, and B. Dalkiran Aldosterone-induced endothelial dysfunction of rat aorta: role of poly(ADP-ribose) activation Journal of Renin-Angiotensin-Aldosterone System, September 1, 2009; 10(3): 127 - 137. [Abstract] [PDF] |
||||
![]() |
Q.-q. Wang, Y.-g. Qiu, Y.-j. Zhu, J.-h. Zhu, L.-h. Wang, X.-s. Hu, S.-j. Hu, L.-r. Zheng, Q.-m. Tao, F.-r. Zhang, et al. Cyclophosphamide protects against myocardial ischemia/reperfusion injury in rats: One of the therapeutic targets is high sensitivity C-reactive protein J. Thorac. Cardiovasc. Surg., April 1, 2009; 137(4): 991 - 996. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhu, Y. Qiu, Q. Wang, Y. Zhu, S. Hu, L. Zheng, L. Wang, and Y. Zhang Low dose cyclophosphamide rescues myocardial function from ischemia-reperfusion in rats Eur. J. Cardiothorac. Surg., September 1, 2008; 34(3): 661 - 666. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Metzler, B. Haubner, E. Conci, J. Voelkl, J. Jehle, M. Bauer, D. Wolf, O. Pachinger, and Q. Xu Myocardial ischaemia-reperfusion injury in haematopoietic cell-restricted {beta}1 integrin knockout mice Exp Physiol, July 1, 2008; 93(7): 825 - 833. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Chowdhry, H. A. Vohra, and M. Galinanes Diabetes increases apoptosis and necrosis in both ischemic and nonischemic human myocardium: Role of caspases and poly-adenosine diphosphate-ribose polymerase J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 124 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Z. Zhou, R. A. Swanson, U. Simonis, X. Ma, G. Cecchini, and M. O. Gray Poly(ADP-ribose) polymerase-1 hyperactivation and impairment of mitochondrial respiratory chain complex I function in reperfused mouse hearts Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H714 - H723. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zare, M. Magnusson, T. Bergstrom, M. Brisslert, E. Josefsson, A. Karlsson, and A. Tarkowski Uric acid, a nucleic acid degradation product, down-regulates dsRNA-triggered arthritis J. Leukoc. Biol., March 1, 2006; 79(3): 482 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Sedlak and S. H. Snyder Messenger Molecules and Cell Death: Therapeutic Implications JAMA, January 4, 2006; 295(1): 81 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tapodi, B. Debreceni, K. Hanto, Z. Bognar, I. Wittmann, F. Gallyas Jr., G. Varbiro, and B. Sumegi Pivotal Role of Akt Activation in Mitochondrial Protection and Cell Survival by Poly(ADP-ribose)polymerase-1 Inhibition in Oxidative Stress J. Biol. Chem., October 21, 2005; 280(42): 35767 - 35775. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Kim, T. Zhang, and W. L. Kraus Poly(ADP-ribosyl)ation by PARP-1: `PAR-laying' NAD+ into a nuclear signal Genes & Dev., September 1, 2005; 19(17): 1951 - 1967. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Erdelyi, A. Kiss, E. Bakondi, P. Bai, C. Szabo, P. Gergely, F. Erdodi, and L. Virag Gallotannin Inhibits the Expression of Chemokines and Inflammatory Cytokines in A549 Cells Mol. Pharmacol., September 1, 2005; 68(3): 895 - 904. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kitamura, M. Sekimata, S.-i. Kikuchi, and Y. Homma Involvement of poly(ADP-ribose) polymerase 1 in ERBB2 expression in rheumatoid synovial cells Am J Physiol Cell Physiol, July 1, 2005; 289(1): C82 - C88. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Andrasi, A. Blazovics, G. Szabo, C. F. Vahl, and S. Hagl Poly(ADP-ribose) polymerase inhibitor PJ-34 reduces mesenteric vascular injury induced by experimental cardiopulmonary bypass with cardiac arrest Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2972 - H2978. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S.A. Patel, U. Cortes, R. Di Poala, E. Mazzon, H. Mota-Filipe, S. Cuzzocrea, Z.-Q. Wang, and C. Thiemermann Mice Lacking the 110-kD Isoform of Poly(ADP-Ribose) Glycohydrolase Are Protected against Renal Ischemia/Reperfusion Injury J. Am. Soc. Nephrol., March 1, 2005; 16(3): 712 - 719. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Szabo, P. Soos, U. Heger, C. Flechtenmacher, S. Bahrle, Z. Zsengeller, C. Szabo, and S. Hagl Poly(ADP-ribose) polymerase inhibition attenuates biventricular reperfusion injury after orthotopic heart transplantation Eur. J. Cardiothorac. Surg., February 1, 2005; 27(2): 226 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Genovese, E. Mazzon, C. Muia, N. S. A. Patel, M. D. Threadgill, P. Bramanti, A. De Sarro, C. Thiemermann, and S. Cuzzocrea Inhibitors of Poly(ADP-Ribose) Polymerase Modulate Signal Transduction Pathways and Secondary Damage in Experimental Spinal Cord Trauma J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 449 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zheng, K. Devalaraja-Narashimha, K. Singaravelu, and B. J. Padanilam Poly(ADP-ribose) polymerase-1 gene ablation protects mice from ischemic renal injury Am J Physiol Renal Physiol, February 1, 2005; 288(2): F387 - F398. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pacher, A. Vaslin, R. Benko, J. G. Mabley, L. Liaudet, G. Hasko, A. Marton, S. Batkai, M. Kollai, and C. Szabo A New, Potent Poly(ADP-ribose) Polymerase Inhibitor Improves Cardiac and Vascular Dysfunction Associated with Advanced Aging J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 485 - 491. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Scott, R. B. Kean, T. Mikheeva, M. J. Fabis, J. G. Mabley, C. Szabo, and D. C. Hooper The Therapeutic Effects of PJ34 [N-(6-Oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a Selective Inhibitor of Poly(ADP-Ribose) Polymerase, in Experimental Allergic Encephalomyelitis Are Associated with Immunomodulation J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 1053 - 1061. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chen, Z. Zsengeller, C.-Y. Xiao, and C. Szabo Mitochondrial-to-nuclear translocation of apoptosis-inducing factor in cardiac myocytes during oxidant stress: potential role of poly(ADP-ribose) polymerase-1 Cardiovasc Res, September 1, 2004; 63(4): 682 - 688. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Xiao, M. Chen, Z. Zsengeller, and C. Szabo Poly(ADP-Ribose) Polymerase Contributes to the Development of Myocardial Infarction in Diabetic Rats and Regulates the Nuclear Translocation of Apoptosis-Inducing Factor J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 498 - 504. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lancel, S. Tissier, S. Mordon, X. Marechal, F. Depontieu, A. Scherpereel, C. Chopin, and R. Neviere Peroxynitrite decomposition catalysts prevent myocardial dysfunction and inflammation in endotoxemic rats J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2348 - 2358. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Szabo, P. Soos, S. Bahrle, Z. Zsengeller, C. Flechtenmacher, S. Hagl, and C. Szabo Role of poly(ADP-ribose) polymerase activation in the pathogenesis of cardiopulmonary dysfunction in a canine model of cardiopulmonary bypass Eur. J. Cardiothorac. Surg., May 1, 2004; 25(5): 825 - 832. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Ha Defective transcription factor activation for proinflammatory gene expression in poly(ADP-ribose) polymerase 1-deficient glia PNAS, April 6, 2004; 101(14): 5087 - 5092. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zingarelli, P. W. Hake, M. O'Connor, A. Denenberg, H. R. Wong, S. Kong, and B. J. Aronow Differential regulation of activator protein-1 and heat shock factor-1 in myocardial ischemia and reperfusion injury: role of poly(ADP-ribose) polymerase-1 Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1408 - H1415. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Szabo, L. Liaudet, S. Hagl, and C. Szabo Poly(ADP-ribose) polymerase activation in the reperfused myocardium Cardiovasc Res, February 15, 2004; 61(3): 471 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Szabo, V. Buhmann, T. Andrasi, N. Stumpf, S. Bahrle, V. Kekesi, S. Hagl, C. Szabo, and A. Juhasz-Nagy Poly-ADP-ribose polymerase inhibition protects against myocardial and endothelial reperfusion injury after hypothermic cardiac arrest J. Thorac. Cardiovasc. Surg., September 1, 2003; 126(3): 651 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-S. Cho and C. Chae Evidence of Nitric Oxide Synthase 2 Activity in Swine Naturally Infected with Actinobacillus pleuropneumoniae Vet. Pathol., May 1, 2003; 40(3): 276 - 282. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Andreone, M. O'Connor, A. Denenberg, P. W. Hake, and B. Zingarelli Poly(ADP-Ribose) Polymerase-1 Regulates Activation of Activator Protein-1 in Murine Fibroblasts J. Immunol., February 15, 2003; 170(4): 2113 - 2120. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. McDowell, K. Gammon, B. Zingarelli, C. J. Bachurski, B. J. Aronow, D. R. Prows, and G. D. Leikauf Inhibition of Nitric Oxide Restores Surfactant Gene Expression following Nickel-Induced Acute Lung Injury Am. J. Respir. Cell Mol. Biol., February 1, 2003; 28(2): 188 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.a. Pacher, L. Liaudet, J. G. Mabley, K. Komjati, and C. Szabo Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure J. Am. Coll. Cardiol., September 4, 2002; 40(5): 1006 - 1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Virag and C. Szabo The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors Pharmacol. Rev., September 1, 2002; 54(3): 375 - 429. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Khandoga, G. Enders, P. Biberthaler, and F. Krombach Poly(ADP-ribose) polymerase triggers the microvascular mechanisms of hepatic ischemia-reperfusion injury Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G553 - G560. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pacher, L. Liaudet, P. Bai, L. Virag, J. G. Mabley, G. Hasko, and C. Szabo Activation of Poly(ADP-Ribose) Polymerase Contributes to Development of Doxorubicin-Induced Heart Failure J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 862 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. ZINGARELLI, P. W. HAKE, Z. YANG, M. O'CONNOR, A. DENENBERG, and H. R. WONG Absence of inducible nitric oxide synthase modulates early reperfusion-induced NF-{kappa}B and AP-1 activation and enhances myocardial damage FASEB J, March 1, 2002; 16(3): 327 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Faro, Y. Toyoda, J. D. McCully, P. Jagtap, E. Szabo, L. Virag, C. Bianchi, S. Levitsky, C. Szabo, and F. W. Sellke Myocardial protection by PJ34, a novel potent poly (ADP-ribose) synthetase inhibitor Ann. Thorac. Surg., February 1, 2002; 73(2): 575 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. LIAUDET, P. PACHER, J. G. MABLEY, L. VIRAG, F. G. SORIANO, G. HASKO, and C. SZABO Activation of Poly(ADP-Ribose) Polymerase-1 Is a Central Mechanism of Lipopolysaccharide-Induced Acute Lung Inflammation Am. J. Respir. Crit. Care Med., February 1, 2002; 165(3): 372 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pacher, L. Liaudet, F. G. Soriano, J. G. Mabley, E. Szabo, and C. Szabo The Role of Poly(ADP-Ribose) Polymerase Activation in the Development of Myocardial and Endothelial Dysfunction in Diabetes Diabetes, February 1, 2002; 51(2): 514 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tikoo, S. S. Lau, and T. J. Monks Histone H3 Phosphorylation Is Coupled to Poly-(ADP-Ribosylation) during Reactive Oxygen Species-Induced Cell Death in Renal Proximal Tubular Epithelial Cells Mol. Pharmacol., August 1, 2001; 60(2): 394 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Halmosi, Z. Berente, E. Osz, K. Toth, P. Literati-Nagy, and B. Sumegi Effect of Poly(ADP-Ribose) Polymerase Inhibitors on the Ischemia-Reperfusion-Induced Oxidative Cell Damage and Mitochondrial Metabolism in Langendorff Heart Perfusion System Mol. Pharmacol., June 1, 2001; 59(6): 1497 - 1505. [Abstract] [Full Text] |
||||
![]() |
B Zingarelli, Z Yang, P W Hake, A Denenberg, and H R Wong Absence of endogenous interleukin 10 enhances early stress response during post-ischaemic injury in mice intestine Gut, May 1, 2001; 48(5): 610 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Ha, K. Juluri, Y. Zhou, S. Leung, M. Hermankova, and S. H. Snyder Poly(ADP-ribose) polymerase-1 is required for efficient HIV-1 integration PNAS, March 1, 2001; (2001) 51633498. [Abstract] [Full Text] |
||||
![]() |
C. M. Simbulan-Rosenthal, D. S. Rosenthal, R. Luo, J.-H. Li, J. Zhang, and M. E. Smulson Inhibition of poly(ADP-ribose) polymerase activity is insufficient to induce tetraploidy Nucleic Acids Res., February 1, 2001; 29(3): 841 - 849. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Metzler, J. Mair, A. Lercher, C. Schaber, F. Hintringer, O. Pachinger, and Q. Xu Mouse model of myocardial remodelling after ischemia: role of intercellular adhesion molecule-1 Cardiovasc Res, February 1, 2001; 49(2): 399 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Satoh, I. Date, M. Nakajima, K. Takahashi, K. Iseda, T. Tamiya, T. Ohmoto, Y. Ninomiya, S. Asari, and R. L. Macdonald Inhibition of Poly(ADP-Ribose) Polymerase Attenuates Cerebral Vasospasm After Subarachnoid Hemorrhage in Rabbits Editorial Comment Stroke, January 1, 2001; 32(1): 225 - 231. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kiarash, P. J. Pagano, M. Tayeh, N.-E. Rhaleb, and O. A. Carretero Upregulated Expression of Rat Heart Intercellular Adhesion Molecule-1 in Angiotensin II- but Not Phenylephrine- Induced Hypertension Hypertension, January 1, 2001; 37(1): 58 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. S. Chiang and T. T. Lam Post-Treatment at 12 or 18 Hours with 3-Aminobenzamide Ameliorates Retinal Ischemia-Reperfusion Damage Invest. Ophthalmol. Vis. Sci., September 1, 2000; 41(10): 3210 - 3214. [Abstract] [Full Text] |
||||
![]() |
H. B Jijon, T. Churchill, D. Malfair, A. Wessler, L. D Jewell, H. G Parsons, and K. L Madsen Inhibition of poly(ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis Am J Physiol Gastrointest Liver Physiol, September 1, 2000; 279(3): G641 - G651. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liaudet, F. G. Soriano, E. Szabó, L. Virág, J. G. Mabley, A. L. Salzman, and C. Szabó Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase PNAS, August 17, 2000; (2000) 170226797. [Abstract] [Full Text] |
||||
![]() |
Z. Yang, B. Zingarelli, and C. Szabo Crucial Role of Endogenous Interleukin-10 Production in Myocardial Ischemia/Reperfusion Injury Circulation, March 7, 2000; 101(9): 1019 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Pieper, S. Blackshaw, E. E. Clements, D. J. Brat, D. K. Krug, A. J. White, P. Pinto-Garcia, A. Favit, J. R. Conover, S. H. Snyder, et al. Poly(ADP-ribosyl)ation basally activated by DNA strand breaks reflects glutamate-nitric oxide neurotransmission PNAS, February 15, 2000; 97(4): 1845 - 1850. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Ha and S. H. Snyder Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion PNAS, November 23, 1999; 96(24): 13978 - 13982. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. STERN, A. SALZMAN, R. T. COTTON, and B. ZINGARELLI Protective Effect of 3-Aminobenzamide, an Inhibitor of Poly (ADP-Ribose) Synthetase, against Laryngeal Injury in Rats Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): 1743 - 1749. [Abstract] [Full Text] |
||||
![]() |
E. J. Pulido, B. D. Shames, C. H. Selzman, H. A. Barton, A. Banerjee, D. D. Bensard, and R. C. McIntyre Jr. Inhibition of PARS attenuates endotoxin-induced dysfunction of pulmonary vasorelaxation Am J Physiol Lung Cell Mol Physiol, October 1, 1999; 277(4): L769 - L776. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Pieper, D. J. Brat, D. K. Krug, C. C. Watkins, A. Gupta, S. Blackshaw, A. Verma, Z.-Q. Wang, and S. H. Snyder Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes PNAS, March 16, 1999; 96(6): 3059 - 3064. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Ha, K. Juluri, Y. Zhou, S. Leung, M. Hermankova, and S. H. Snyder Poly(ADP-ribose) polymerase-1 is required for efficient HIV-1 integration PNAS, March 13, 2001; 98(6): 3364 - 3368. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Ha, L. D. Hester, and S. H. Snyder Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia PNAS, March 5, 2002; 99(5): 3270 - 3275. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liaudet, F. G. Soriano, E. Szabo, L. Virag, J. G. Mabley, A. L. Salzman, and C. Szabo Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase PNAS, August 29, 2000; 97(18): 10203 - 10208. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Szabo, S. Bahrle, N. Stumpf, K. Sonnenberg, E. Szabo, P. Pacher, T. Csont, R. Schulz, T. J. Dengler, L. Liaudet, et al. Poly(ADP-Ribose) Polymerase Inhibition Reduces Reperfusion Injury After Heart Transplantation Circ. Res., January 11, 2002; 90(1): 100 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Soriano, P. Pacher, J. Mabley, L. Liaudet, and C. Szabo Rapid Reversal of the Diabetic Endothelial Dysfunction by Pharmacological Inhibition of Poly(ADP-Ribose) Polymerase Circ. Res., October 12, 2001; 89(8): 684 - 691. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |